| Title: | Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9 |
| Authors: | Phillipson, LJ Segal, DH Nero, TL Parker, MW Wan, SS de Silva, M Guthridge, MA Wei, AH Burns, CJ |
| Issue Year: | 2015 |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Series | BIOORGANIC & MEDICINAL CHEMISTRY: 23(19):6280-9 |
| Abstract | The serine-threonine kinase CDK9 is a target of emerging interest for the development of anti-cancer drugs. There are multiple lines of evidence linking CDK9 activity to cancer, including the essential role this kinase plays in transcriptional regulation through phosphorylation of the C-terminal domain (CTD) of RNA polymerase II. Indeed, inhibition of CDK9 has been shown to result in a reduction of short-lived proteins such as the pro-survival protein Mcl-1 in malignant cells leading to the induction of apoptosis. In this work we report our initial studies towards the discovery of selective CDK9 inhibitors, starting from the known multi-kinase inhibitor PIK-75 which possesses potent CDK9 activity. Our series is based on a pyrazolo[1,5-a]pyrimidine nucleus and, importantly, the resultant lead compound 18b is devoid of the structural liabilities present in PIK-75 and possesses greater selectivity. |
| URI: | https://publications.svi.edu.au/publications/1950 |
| Other Identifiers | doi: 10.1016/j.bmc.2015.08.035. Epub 2015 Aug 2 |
| Publication type | Article |
| Grant ID | GNT1021645 |